| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
22,283 |
17,308 |
$886K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,838 |
1,806 |
$166K |
| 99000 |
|
14,577 |
12,584 |
$163K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,646 |
1,598 |
$162K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,549 |
2,326 |
$144K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,467 |
1,429 |
$125K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
10,869 |
5,140 |
$115K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,835 |
1,770 |
$83K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,148 |
2,038 |
$59K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
653 |
638 |
$54K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,585 |
3,426 |
$53K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,307 |
6,788 |
$48K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,733 |
3,483 |
$31K |
| 80061 |
Lipid panel |
3,138 |
2,904 |
$31K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,151 |
1,087 |
$30K |
| 97802 |
|
5,156 |
4,822 |
$22K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,570 |
1,454 |
$22K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,373 |
1,765 |
$20K |
| 99429 |
|
631 |
616 |
$17K |
| 83655 |
|
1,304 |
1,243 |
$14K |
| 92552 |
|
4,254 |
4,115 |
$10K |
| 81000 |
|
2,264 |
2,103 |
$8K |
| 99241 |
|
904 |
816 |
$8K |
| 90461 |
|
1,106 |
900 |
$7K |
| 82652 |
|
881 |
816 |
$6K |
| 87807 |
|
452 |
443 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,712 |
1,594 |
$5K |
| 99242 |
|
59 |
56 |
$4K |
| 99050 |
|
323 |
316 |
$4K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
42 |
41 |
$4K |
| 0071A |
|
104 |
100 |
$4K |
| 0002A |
|
90 |
87 |
$4K |
| 0072A |
|
96 |
96 |
$4K |
| 0001A |
|
80 |
80 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,307 |
1,257 |
$3K |
| S9441 |
Asthma education, non-physician provider, per session |
145 |
134 |
$3K |
| 86328 |
|
68 |
59 |
$2K |
| 82947 |
|
1,281 |
1,222 |
$2K |
| 87081 |
|
2,915 |
2,816 |
$2K |
| 84439 |
|
1,366 |
1,284 |
$2K |
| 80050 |
General health panel |
45 |
45 |
$1K |
| 80053 |
Comprehensive metabolic panel |
2,204 |
2,057 |
$1K |
| 36410 |
|
95 |
93 |
$1K |
| 96160 |
|
477 |
471 |
$1K |
| 69210 |
|
26 |
24 |
$863.13 |
| 98960 |
|
45 |
43 |
$568.10 |
| 0003A |
|
12 |
12 |
$524.00 |
| 87088 |
|
568 |
523 |
$174.20 |
| 36416 |
|
4,559 |
4,287 |
$169.89 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
65 |
64 |
$158.00 |
| 90686 |
|
2,075 |
2,040 |
$157.98 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
17 |
17 |
$149.71 |
| 90756 |
|
44 |
44 |
$86.35 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
544 |
512 |
$53.39 |
| 36415 |
Collection of venous blood by venipuncture |
3,320 |
3,048 |
$40.45 |
| 99401 |
|
1,494 |
1,417 |
$24.26 |
| 94760 |
|
122 |
113 |
$9.40 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
189 |
187 |
$1.86 |
| 90620 |
|
358 |
346 |
$0.52 |
| 90734 |
|
287 |
274 |
$0.10 |
| 90651 |
|
318 |
316 |
$0.06 |
| 90715 |
|
127 |
124 |
$0.04 |
| 90619 |
|
198 |
197 |
$0.01 |
| 90670 |
|
628 |
605 |
$0.00 |
| 90671 |
|
136 |
134 |
$0.00 |
| 90707 |
|
301 |
286 |
$0.00 |
| 99173 |
|
3,790 |
3,664 |
$0.00 |
| 90633 |
|
332 |
310 |
$0.00 |
| 90649 |
|
485 |
427 |
$0.00 |
| 91300 |
|
271 |
245 |
$0.00 |
| 90672 |
|
29 |
29 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
89 |
83 |
$0.00 |
| 90700 |
|
14 |
14 |
$0.00 |
| 80076 |
|
14 |
12 |
$0.00 |
| 90685 |
|
37 |
36 |
$0.00 |
| 1031F |
|
2,243 |
2,178 |
$0.00 |
| 90716 |
|
311 |
296 |
$0.00 |
| 90647 |
|
384 |
362 |
$0.00 |
| 90696 |
|
33 |
30 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
2,776 |
2,679 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
468 |
456 |
$0.00 |
| 82962 |
|
1,608 |
1,519 |
$0.00 |
| 96127 |
|
101 |
100 |
$0.00 |
| 90680 |
|
265 |
257 |
$0.00 |
| 91307 |
|
222 |
188 |
$0.00 |
| 90723 |
|
36 |
36 |
$0.00 |
| 84436 |
|
18 |
18 |
$0.00 |
| 90697 |
|
25 |
25 |
$0.00 |
| 1005F |
|
28 |
28 |
$0.00 |
| 90677 |
|
13 |
13 |
$0.00 |
| 96161 |
|
41 |
41 |
$0.00 |